Thanks for joining DividendStocks.com, the daily newsletter built for dividend and income investors like you. We’re thrilled to have you on board and can’t wait to help you discover the best dividend opportunities out there. Before we can start sending your daily insights, please take a quick moment to confirm your subscription: Click Here to Confirm Your Subscription to DividendStocks.com Here’s a small glimpse of what you’ll get access to: Dividend Stock Ideas — Each newsletter features dividend stocks with high yields, sustainable payouts, and strong growth potential. Ex-Dividend Stocks — Want to capture upcoming dividend payouts? Find out which stocks are going ex-dividend this week. Market News and Events — Stay in the loop on the latest developments impacting popular dividend names like AT&T, Exxon Mobil, IBM, Procter & Gamble, and Verizon. Bonus: As a thank-you for confirming, you’ll also receive a free PDF copy of Automatic Income, our popular guide to building wealth through dividend investing. Why wait? Let’s get your dividend journey started! Click Here to Start Discovering Top Income-Generating Stocks See you in your inbox soon,
The DividendStocks.com Team P.S. Don’t miss out click here to verify your subscription and secure your daily dividend insights and your free investing guide!
This Month's Exclusive Story Small-Cap Standouts: These 3 Stocks Rose Over 300% in 2025Submitted by Leo Miller. Published: 1/3/2026. 
Quick Look - While small caps as a whole generated lower returns than large caps in 2025, three interesting names bucked this narrative.
- A cancer screening company and two satellite operators saw their shares rise 300% or more.
- See where analysts are forecasting upside and understand vital considerations pertaining to smaller stocks.
In 2025, small-cap stocks underperformed: the Russell 2000 Index, which tracks 2,000 U.S. small-cap stocks, returned about 13%, compared with the S&P 500 Index's roughly 18%, which tracks U.S. large-cap stocks. Despite this lag, three small-cap names stood out, each rising more than 300% in 2025. We focus on stocks that began 2025 in small-cap territory but, because of their sizable gains, have since moved into mid-cap status. GRAL Catapults on Early Cancer Detection Enthusiasm Gold Headed Above $5,000 per Ounce in 2026? Here's How to Play It...
With so many strange events happening across the economy (consumer confidence plummeting, credit-card delinquencies soaring, and more), it's no wonder the richest investors are loading up on gold. But what you might not realize is that there's a much better way to profit from rising gold prices - WITHOUT ever touching an ETF, mining stock, or even bullion. Get the full details here. Healthcare stock GRAIL (NASDAQ: GRAL) climbed roughly 380% in 2025, lifting its market capitalization from well under $1 billion to about $3.3 billion. The company's flagship product is the Galleri Multi-Cancer Early Detection test. Early detection improves survival rates, which has driven interest in Galleri. Only about five cancers currently have standardized screening methods, yet roughly 70% of cancer deaths come from other types. Galleri was designed to detect more than 50 different cancers. In a recent study, GRAIL reported Galleri increased early cancer detection more than sevenfold when added to traditional screening. Most Galleri sales today are out-of-pocket, but GRAIL expects to apply for Premarket Approval (PMA) from the U.S. Food and Drug Administration in the first quarter of 2026. Approval would materially raise the likelihood of commercial-insurer coverage and could open a large new sales channel, which is fueling investor enthusiasm. The MarketBeat consensus price target of $97.50 reflects analyst optimism, implying roughly 14% upside. PL Blasts Off, Combining AI with Geospatial Imagery Planet Labs PBC (NYSE: PL) had a standout 2025, with shares rising just under 390%. The company operates hundreds of satellites to collect medium- to high-resolution Earth imagery and combines that data with artificial intelligence to help customers make better decisions. Revenue comes from subscriptions to its cloud-based platform and satellite services. Demand is materializing—especially among government customers. Its Dec. 10 earnings report pushed shares up about 35% in one day, with defense and intelligence revenue rising more than 70%. The firm reported a backlog of roughly $735 million—about 2.6 times its trailing 12-month revenue of $282 million—suggesting meaningful growth potential. Planet Labs also posted positive free cash flow for the second consecutive quarter. The MarketBeat consensus price target of $14.74 implies about 25% downside, but the average of targets updated after the company's latest earnings is $18.19, which implies roughly 7.7% downside. Planet Labs remains worth watching; a significant pullback could make the stock more attractive. Updated Targets Eye Strong Upside in VSAT After Huge 2025 Run Last up is Viasat (NASDAQ: VSAT), which rose roughly 305% in 2025 and now has a market cap near $4.7 billion. Viasat focuses on internet and data connectivity—somewhat similar to AST SpaceMobile (NASDAQ: ASTS)—but its customers are primarily in aviation, maritime and government markets rather than consumer telecom. Viasat provides in-flight wireless connectivity to thousands of commercial and business aircraft. The U.S. government was the company's largest customer in fiscal 2025, accounting for 18% of revenue; Viasat is currently in fiscal 2026. Revenues grew about 2% last quarter, but contract awards rose 17% to nearly $1.5 billion and backlog climbed to almost $3.9 billion. The MarketBeat consensus price target of $32.75 implies roughly 5% downside. However, targets updated after the company's Nov. 7 earnings average $49, suggesting about 37% upside potential. GRAL, PL, VSAT: Deep Research Is Paramount GRAL, PL and VSAT delivered exceptional returns in 2025, but investors should remember that smaller stocks that run hard can be highly volatile and risky. Confidence in each company's long-term outlook and thorough due diligence are essential before considering an investment in these names.
| 
